Finance

Lists
688089:SHA
Cabio Biotech Wuhan Co Ltd
8,19 CN¥
+1,36%
(+0,11) 1D
16 қаз., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688089...
Open
8,10 CN¥
High
8,28 CN¥
Low
8,06 CN¥
Mkt. cap
1,34 млрд
Avg. vol.
1,39 млн
Volume
988,49 м.
52-wk high
26,25 CN¥
52-wk low
6,91 CN¥
EPS
-0,38 CN¥
No. of employees
500
Open
8,10 CN¥
High
8,28 CN¥
Low
8,06 CN¥
Mkt. cap
1,34 млрд
Avg. vol.
1,39 млн
Volume
988,49 м.
52-wk high
26,25 CN¥
52-wk low
6,91 CN¥
EPS
-0,38 CN¥
No. of employees
500
News stories
From web sources and news partners
About Cabio Biotech Wuhan Co Ltd
CEO-
Employees500
Founded1999
Headquarters-
SectorSpeciality chemicals
Websitecabio.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
121,30 млн
135,11 млн
11,01 млн
46,58 млн
Cost of goods sold
63,86 млн
93,16 млн
22,03 млн
74,54 млн
Cost of revenue
63,86 млн
93,16 млн
22,03 млн
74,54 млн
Research and development expenses
11,66 млн
15,87 млн
10,53 млн
9,12 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,15 млн
19,34 млн
15,22 млн
17,35 млн
Operating expense
28,15 млн
46,02 млн
29,66 млн
32,16 млн
Total operating expenses
92,01 млн
139,18 млн
51,69 млн
106,71 млн
Operating income
29,28 млн
-4,07 млн
-40,68 млн
-60,13 млн
Other non operating income
12,91 млн
-13,56 млн
-2,55 млн
3,16 млн
EBT including unusual items
23,90 млн
15,24 млн
-45,11 млн
-61,05 млн
EBT excluding unusual items
37,34 млн
-16,20 млн
-43,87 млн
-61,72 млн
Income tax expense
3,40 млн
2,82 млн
-
-2,29 млн
Effective tax rate
14,21%
18,53%
-
3,76%
Other operating expenses
1,61 млн
2,02 млн
956,55 м.
2,36 млн
Net income
21,39 млн
14,38 млн
-43,57 млн
-57,01 млн
Net profit margin
17,64%
10,64%
-395,55%
-122,40%
Earnings per share
-
-
-
-
Interest and investment income
-
1,19 млн
246,78 м.
471,87 м.
Interest expense
-1,28 млн
-568,40 м.
-886,27 м.
-1,30 млн
Net interest expenses
-1,28 млн
621,00 м.
-639,48 м.
-831,00 м.
Depreciation and amortization charges
-
-
-
-
EBITDA
42,85 млн
10,92 млн
-25,69 млн
-40,77 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары